Reduced MEF2D expression has been directly linked to reduced levels of nicotinamide adenine dinucleotide dehydrogenase 6 (NADH), a component of mitochondrial complex I. Post-mortem analysis of brain samples from PD patients revealed reduced levels of both MEF2D and NADH [137]. This evidence concerns the gene MEF2D and Parkinson disease.